Period of concomitant medication use relative to lasmiditan administration | Concomitant medication type | Number of times concomitantly administered n (%)a |
---|---|---|
From 24 h to immediately prior to lasmiditan administration | Ergot alkaloids | 1 (0.0) |
NSAIDs | 251 (2.9) | |
Triptans | 112 (1.3) | |
From 0 to < 2 h after lasmiditan administration | Ergot alkaloids | 0 |
NSAIDs | 96 (1.1) | |
Triptans | 64 (0.7) | |
From 2 to < 24 h after lasmiditan administration | Ergot alkaloids | 12 (0.1) |
NSAIDs | 471 (5.4) | |
Triptans | 365 (4.2) |